Through a new partnership, Serve You Rx is leveraging Waltz Health’s AI-powered specialty pharmacy platform. The post Serve You Rx Teams Up with Waltz Health to Advance Specialty Pharmacy appeared first on MedCity News.
This data note reviews trends in homelessness and characteristics of people who are homeless using data from HUD’s Point-in-Time (PIT) count of sheltered and unsheltered people experiencing homelessness.
We are entering an age of at home testing and the team at Reperio just raised $14m to make weight, blood pressure and cholesterol/blood sugar testing available at home. But this is a relatively complex series of tests, intended to get people who haven’t been to a primary care doctor back into the system. How…
In this JAMA Health Forum post, Executive Vice President Larry Levitt recalls the mid-1990s’ public backlash against Health Maintenance Organizations (commonly known as HMOs) – all of which preceded the recent outpouring of health insurance concerns – as well as how consumer protections against coverage restrictions have evolved and fallen short.
Phil Fasano is CEO of Recuro Health. Phil was CIO at Kaiser Permanente in the glory years when it rolled out Epic/Health Connect, which was at the time the biggest roll out of an EMR and was instrumental in creating Kaiser’s system of virtual care. A decade+ later the concept of telehealth and virtual care…
HELENA, Mont. — Montana’s small, independent pharmacies say they’re getting increasingly squeezed on reimbursements by pharmacy benefit managers — and are pushing an ambitious bill to rein in what they say are unfair practices by the powerful industry negotiators known as PBMs. “Who in their right mind would subject themselves to this sort of treatment…
Homeless shelters and FQHCs will begin using a common platform to improve care coordination
El vestíbulo de la clínica comunitaria St. John’s Community Health en el sur de Los Ángeles está repleto de pacientes, pero a la trabajadora de salud comunitaria Ana Ruth Varela le preocupa que todo se vuelva mucho más tranquilo. Dijo que muchos pacientes tienen miedo de salir de sus casas. “El otro día hablé con…
Takeda said more than half of plaque psoriasis patients treated with zasocitinib achieved clear or almost clear skin in two Phase 3 studies. Regulatory submissions for the TYK2 inhibitor are planned for 2026 and clinical trials are ongoing in other indications. The post Takeda Drug From $4B Deal Succeeds in Two Pivotal Plaque Psoriasis Trials…